Xiaoyin Bai

977 total citations
67 papers, 505 citations indexed

About

Xiaoyin Bai is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Xiaoyin Bai has authored 67 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 27 papers in Genetics and 26 papers in Epidemiology. Recurrent topics in Xiaoyin Bai's work include Inflammatory Bowel Disease (24 papers), Pancreatitis Pathology and Treatment (13 papers) and Microscopic Colitis (11 papers). Xiaoyin Bai is often cited by papers focused on Inflammatory Bowel Disease (24 papers), Pancreatitis Pathology and Treatment (13 papers) and Microscopic Colitis (11 papers). Xiaoyin Bai collaborates with scholars based in China, United States and Sweden. Xiaoyin Bai's co-authors include Hong Yang, Jiaming Qian, Mingyue Guo, Meng Jin, Huimin Zhang, Bo Lü, Wei Han, Yi Li, Yamin Lai and Lingjuan Jiang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Xiaoyin Bai

56 papers receiving 503 citations

Peers

Xiaoyin Bai
Peter Neary Ireland
Mehmet Özeren Türkiye
Tim Mould United Kingdom
Xiaoqing Xu China
Kyu Ri Hwang South Korea
Yong Beom Kim South Korea
Marc I. Brand United States
Hüseyin Abalı Türkiye
Paul Friedlander United States
Peter Neary Ireland
Xiaoyin Bai
Citations per year, relative to Xiaoyin Bai Xiaoyin Bai (= 1×) peers Peter Neary

Countries citing papers authored by Xiaoyin Bai

Since Specialization
Citations

This map shows the geographic impact of Xiaoyin Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyin Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyin Bai more than expected).

Fields of papers citing papers by Xiaoyin Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyin Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyin Bai. The network helps show where Xiaoyin Bai may publish in the future.

Co-authorship network of co-authors of Xiaoyin Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyin Bai. A scholar is included among the top collaborators of Xiaoyin Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyin Bai. Xiaoyin Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Jing, Weixun Zhou, Xue Zhao, et al.. (2025). Comparison of Radiomics and Deep Learning Using Intestinal Ultrasound Images for Differentiating Inflammatory and Fibrotic Intestinal Strictures in Crohn’s Disease. Journal of Inflammation Research. Volume 18. 16399–16410.
2.
Bai, Xiaoyin, et al.. (2025). Possible linking and treatment between Parkinson’s disease and inflammatory bowel disease: a study of Mendelian randomization based on gut–brain axis. Journal of Translational Medicine. 23(1). 45–45. 1 indexed citations
3.
Wang, Zheng, Lingjuan Jiang, Xiaoyin Bai, et al.. (2025). Vitamin D receptor regulates methyltransferase like 14 to mitigate colitis-associated colorectal cancer. Journal of genetics and genomics. 52(8). 1011–1020. 2 indexed citations
4.
5.
Zhang, Mengmeng, Hong Lv, Xiaoyin Bai, et al.. (2025). Disrupted mitochondrial morphology and function exacerbate inflammation in elderly-onset ulcerative colitis. Immunity & Ageing. 22(1). 4–4.
6.
Sun, Ying, Xiaoyin Bai, Tao Guo, et al.. (2024). Rare digestive disease: Mitochondrial neurogastrointestinal encephalomyopathy, review of the literature. Journal of Digestive Diseases. 25(9-10). 624–631.
7.
Guo, Mingyue, et al.. (2024). A Shortened Diagnostic Interval and Its Associated Clinical Factors and Related Outcomes in Inflammatory Bowel Disease Patients from a Cohort Study in China. Journal of Inflammation Research. Volume 17. 387–398. 4 indexed citations
8.
Mi, Jiarui, Qingwei Jiang, Zhengwei Qi, et al.. (2024). Plasma campesterol and ABCG5/ABCG8 gene loci on the risk of cholelithiasis and cholecystitis: evidence from Mendelian randomization and colocalization analyses. Human Genomics. 18(1). 19–19. 1 indexed citations
9.
10.
Wang, Yabing, Jianing Li, Xiaoyin Bai, et al.. (2023). Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 14. 1131974–1131974. 2 indexed citations
11.
Yan, Zhiyu, Xiaoyan Chang, Xiaoyin Bai, et al.. (2023). Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma. HepatoBiliary Surgery and Nutrition. 12(6). 997–1000. 1 indexed citations
12.
Yu, Ziqing, Xiaoyin Bai, Mingyue Guo, et al.. (2023). Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019. International Journal of Cancer. 154(4). 615–625. 41 indexed citations
13.
14.
Lu, Bo, et al.. (2022). [Short-term efficacy and safety of vedolizumab in patients with inflammatory bowel disease].. PubMed. 102(42). 3388–3394. 2 indexed citations
15.
Wang, Yuanzhuo, Rui Jin, Tianming Xu, et al.. (2022). Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review. International Immunopharmacology. 105. 108517–108517. 9 indexed citations
16.
Chen, Yang, Xiaoyin Bai, Kaini Shen, et al.. (2022). Clinical features and prognosis of patients with gastrointestinal Behçet's disease-like syndrome and myelodysplastic syndrome with and without trisomy 8. Seminars in Arthritis and Rheumatism. 55. 152039–152039. 10 indexed citations
17.
18.
Mi, Jiarui, Zhengye Liu, Xia Wu, et al.. (2022). Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease. International Immunopharmacology. 110. 109020–109020. 10 indexed citations
19.
Jiang, Lingjuan, Wei Han, Xiaoyin Bai, et al.. (2021). Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis. Frontiers in Immunology. 12. 742080–742080. 13 indexed citations
20.
Jin, Meng, Xiaoyin Bai, Huimin Zhang, et al.. (2019). A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. Journal of clinical lipidology. 13(6). 947–953.e1. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Neary Breakdown of academic impact, for papers by Mehmet Özeren Breakdown of academic impact, for papers by Tim Mould Breakdown of academic impact, for papers by Xiaoqing Xu Breakdown of academic impact, for papers by Kyu Ri Hwang Breakdown of academic impact, for papers by Yong Beom Kim Breakdown of academic impact, for papers by Marc I. Brand Breakdown of academic impact, for papers by Hüseyin Abalı Breakdown of academic impact, for papers by Paul Friedlander
Rankless by CCL
2026